Pharmaceutical

Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in oncology and obesity.

Jan 14, 2025 - 06:00
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025
CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in oncology and obesity.
Read the original article

Tags:

Previous Article

Eli Lilly targets Scorpion Therapeutics to expand reach in oncology

Next Article

Biogen proposes acquisition of partner Sage Therapeutics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: House panel expected to mark up pandemic-preparedness bill next week

STAT+: House panel expected to mark up pandemic-prepare...

Jul 8, 2023

Imunon’s shares soar after IL-12 therapy success in Phase II trial

Imunon’s shares soar after IL-12 therapy success in Pha...

Aug 1, 2024

Opinion: Congress can eradicate hepatitis C and reduce the deficit at the same time

Opinion: Congress can eradicate hepatitis C and reduce ...

Jul 14, 2023